Latest Releases
U.S. Senator Tina Smith Joins Elizabeth Warren, Banking Committee Democrats in Pressing SEC Chair to Require Disclosure of Corporate Lobbying Expenditures
Washington, D.C. — Today, U.S. Senators Tina Smith (D – Minn.), Sherrod Brown (D-Ohio.), Jon Tester (D-Mont.) and John Fetterman (D-Pa.) signed onto a letter led by Senator Elizabeth Warren (D – Mass.) urging Gary Gensler, Chair of the U.S. Securities and Exchange Commission (SEC), to create new rules requiring public companies to disclose their spending on lobbying efforts. Public companies are not currently required to report information on the details of their lobbying to the SEC even as corporate lobbying expenditures reach record highs. “In 2022, total federal lobbying expenditures reached $4.1 billion – the highest since 2010. Amazon and Meta spent almost $20 million each to influence decision-making in Congress and across government agencies, while the U.S. Chamber of Commerce – which counts companies like JPMorgan Chase, Alphabet, and Chevron among its members – spent $79.4 million,” wrote the senators. “While these figures are staggering, they provide little insight into the interests that companies spend millions each year to advance. This lack of transparency erodes the ability of everyday investors to make informed decisions about where to invest their money – and where their money goes once they have invested.” Specifically, the senators are requesting that such rules require disclosure of lobbying strategy, the total amount of direct or indirect contributions to registered state and federal lobbyists and any material risks related to or arising from lobbying strategies and expenditures. The senators requested the SEC provide them with details on their plans to develop and issue such rules no later than
U.S. Senators Tina Smith, Tom Cotton Reintroduce Bipartisan Legislation to Boost U.S. Pharmaceutical Manufacturing
WASHINGTON, D.C. — Today, Senators Tina Smith (D-MN) and Tom Cotton (R-AR) reintroduced bipartisan legislation to reduce dependence on foreign pharmaceutical manufacturing and boost production in the U.S. The pandemic exposed our nation’s dependence on other countries for essential prescription drugs. Seventy-seven percent of key pharmaceutical ingredients come from overseas, including from China, threatening the security of the supply chain and leading to shortages of essential prescription drugs. The American Made Pharmaceuticals Act would reduce our dependence on foreign countries for pharmaceuticals by boosting production here at home. The legislation would create federal incentives to onshore manufacturing of essential medicine, while taking steps to shore up links in the supply chain. “We know that depending on foreign countries for key resources – whether it’s oil or medicine – leaves us vulnerable to global supply chain shocks and shortages,” said Sen. Smith. “This bipartisan legislation would reduce our dependence on foreign pharmaceutical manufacturing and help boost production here at home. I look forward to getting this bill across the finish line so we can relieve prescription drug shortages and build more resilient supply chains.” “The Chinese Communist Party threatened to cut off America’s access to vital drugs during the pandemic,” said Sen. Cotton. “It’s time to bolster onshore manufacturing of pharmaceuticals to ensure Americans never have to rely on China for lifesaving medicine.” “Amneal applauds Senators Smith and Cotton on their targeted approach to increase pharmaceutical manufacturing here in the United States,” said Chirag Patel, President & Co-CEO of Amneal Pharmaceuticals. “Ensuring that
U.S. Senator Tina Smith, Bipartisan Group of Indian Affairs Committee Senators Introduce Bill to Address Law Enforcement, Public Safety Needs in Native Communities
WASHINGTON, D.C. [06/14/2019]—U.S. Senator Tina Smith (D-Minn.) and a bipartisan group of her colleagues on the Senate Indian Affairs Committee—led by Vice Chairman Tom Udall (N.M)—this week introduced the Bridging Agency Data Gaps & Ensuring Safety (BADGES) for Native Communities Act, which would address critical public safety needs in Indian Country. The bill aims to address federal inefficiencies that hurt Bureau of Indian Affairs law enforcement recruitment and retention, increase the effectiveness of federal missing persons resources, and give Tribes and States resources to coordinate responses to the Missing and Murdered Indigenous Women (MMIW) crisis. In addition to Sens. Smith
U.S. Senator Tina Smith: Nation’s Top Trade and Economic Officials Forced to Work with “One Hand Tied Behind Back”
WASHINGTON, D.C. [06/13/2019]—Today, U.S. Senator Tina Smith (D-Minn.) told a Senate Agriculture Committee panel that the Trump Administration’s lack of a clear trade strategy is forcing the nation’s top trade and economic officials to work with one hand tied behind their back, and causing market uncertainty that is driving thousands of already-struggling farmers in Minnesota and across the country into deeper financial distress. At the Senate Agriculture Committee hearing on global market certainty Thursday, Sen. Smith shared stories from Minnesota producers to illustrate how trade uncertainty in the markets is hurting their ability to make decisions, and cutting into
U.S. Senators Smith, Cortez Masto, Scott, Cramer, Young Introduce Bipartisan Bill to Promote Manufactured Housing as Part of Solution to Affordable Housing Crisis
WASHINGTON, D.C. [06/12/2019]—Today, U.S. Senators Tina Smith, (D-Minn.), Catherine Cortez Masto (D-Nev.), Tim Scott (R-S.C.), Kevin Cramer (R-N.D.), and Todd Young (R-Ind.) introduced bipartisan legislation promoting manufactured housing as part of the solution to America’s affordable housing crisis. The HUD Manufactured Housing Modernization Act of 2019 would require the Department of Housing and Urban Development (HUD) to issue guidelines for including manufactured housing in state and local governments’ Consolidated Plans, which outline their housing and community development priorities, when applying for HUD funding. This legislation will ensure that manufactured housing, a significant source of affordable housing, is considered when jurisdictions
U.S. Senator Tina Smith Leads Senate Colleagues in Introducing Comprehensive Bill to Address Skyrocketing Prescription Drug Prices
WASHINGTON D.C. [06/12/19]—Today, U.S. Senator Tina Smith (D-Minn.) introduced comprehensive legislation to hold large pharmaceutical companies accountable for high prices and bring down costs for Americans. Sen. Smith, a member of the Senate Health Committee, said her measure would promote transparency by requiring pharmaceutical companies to disclose just how much money is going toward research and development, as well as marketing and pay for executives. Her bill would also end the restriction that prevents the federal Medicare program from using its buying power to negotiate lower drug prices for its beneficiaries, and curb drug company monopoly practices that keep
English